JP2022545385A5 - - Google Patents

Info

Publication number
JP2022545385A5
JP2022545385A5 JP2022509175A JP2022509175A JP2022545385A5 JP 2022545385 A5 JP2022545385 A5 JP 2022545385A5 JP 2022509175 A JP2022509175 A JP 2022509175A JP 2022509175 A JP2022509175 A JP 2022509175A JP 2022545385 A5 JP2022545385 A5 JP 2022545385A5
Authority
JP
Japan
Prior art keywords
sequence
target dna
polypeptide
rgn
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022509175A
Other languages
English (en)
Japanese (ja)
Other versions
JP7640527B2 (ja
JP2022545385A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/045759 external-priority patent/WO2021030344A1/en
Publication of JP2022545385A publication Critical patent/JP2022545385A/ja
Publication of JP2022545385A5 publication Critical patent/JP2022545385A5/ja
Priority to JP2025025892A priority Critical patent/JP2025086912A/ja
Application granted granted Critical
Publication of JP7640527B2 publication Critical patent/JP7640527B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022509175A 2019-08-12 2020-08-11 Rna誘導ヌクレアーゼ及びその活性断片及び変異体ならびに使用方法 Active JP7640527B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025025892A JP2025086912A (ja) 2019-08-12 2025-02-20 Rna誘導ヌクレアーゼ及びその活性断片及び変異体ならびに使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962885483P 2019-08-12 2019-08-12
US62/885,483 2019-08-12
US201962901875P 2019-09-18 2019-09-18
US62/901,875 2019-09-18
US202063030088P 2020-05-26 2020-05-26
US63/030,088 2020-05-26
PCT/US2020/045759 WO2021030344A1 (en) 2019-08-12 2020-08-11 Rna-guided nucleases and active fragments and variants thereof and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025025892A Division JP2025086912A (ja) 2019-08-12 2025-02-20 Rna誘導ヌクレアーゼ及びその活性断片及び変異体ならびに使用方法

Publications (3)

Publication Number Publication Date
JP2022545385A JP2022545385A (ja) 2022-10-27
JP2022545385A5 true JP2022545385A5 (enExample) 2023-08-21
JP7640527B2 JP7640527B2 (ja) 2025-03-05

Family

ID=72243198

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022509175A Active JP7640527B2 (ja) 2019-08-12 2020-08-11 Rna誘導ヌクレアーゼ及びその活性断片及び変異体ならびに使用方法
JP2025025892A Pending JP2025086912A (ja) 2019-08-12 2025-02-20 Rna誘導ヌクレアーゼ及びその活性断片及び変異体ならびに使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025025892A Pending JP2025086912A (ja) 2019-08-12 2025-02-20 Rna誘導ヌクレアーゼ及びその活性断片及び変異体ならびに使用方法

Country Status (12)

Country Link
US (1) US20220364074A1 (enExample)
EP (1) EP4013864A1 (enExample)
JP (2) JP7640527B2 (enExample)
KR (1) KR20220062289A (enExample)
CN (2) CN114641568B (enExample)
AU (1) AU2020329912A1 (enExample)
BR (1) BR112022002695A2 (enExample)
CA (1) CA3147783A1 (enExample)
IL (1) IL290562A (enExample)
MX (1) MX2022001849A (enExample)
TW (1) TW202120688A (enExample)
WO (1) WO2021030344A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
KR20210149686A (ko) * 2018-12-27 2021-12-09 라이프에디트 테라퓨틱스, 인크. 유전자 편집에 유용한 폴리펩티드 및 사용 방법
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
TW202208626A (zh) 2020-04-24 2022-03-01 美商生命編輯公司 Rna引導核酸酶及其活性片段與變體,以及使用方法
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneously editing two helices of a designated double-helix nucleotide sequence
AU2021300378A1 (en) 2020-07-01 2023-01-19 Elevatebio Technologies, Inc. Compositions and methods for cellular reprogramming using circular RNA
US20240247242A1 (en) 2020-07-15 2024-07-25 LifeEDIT Therapeutics, Inc. Uracil stabilizing proteins and active fragments and variants thereof and methods of use
MX2023002848A (es) 2020-09-11 2023-03-22 Lifeedit Therapeutics Inc Enzimas modificadoras del acido desoxirribonucleico (adn) y fragmentos activos y sus variantes y metodos de uso.
US20240301385A1 (en) * 2021-03-22 2024-09-12 LifeEDIT Therapeutics, Inc. Dna modifying enzymes and active fragments and variants thereof and methods of use
AU2022262623A1 (en) * 2021-04-22 2023-11-30 Emendobio Inc. NOVEL OMNI 117, 140, 150-158, 160-165, 167-177, 180-188, 191-198, 200, 201, 203, 205-209, 211-217, 219, 220, 222, 223, 226, 227, 229, 231-236, 238-245, 247, 250, 254, 256, 257, 260 and 262 CRISPR NUCLEASES
WO2024077267A1 (en) * 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
KR20250126155A (ko) 2022-11-04 2025-08-22 라이프 에디트 테라퓨틱스, 인크. 내부 삽입 부위를 갖는 진화된 아데닌 데아미나제 및 rna-가이드 뉴클레아제 융합 단백질 및 사용 방법
WO2024127370A1 (en) * 2022-12-16 2024-06-20 LifeEDIT Therapeutics, Inc. Guide rnas that target trac gene and methods of use
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
WO2025174908A1 (en) * 2024-02-12 2025-08-21 Life Edit Therapeutics, Inc. Novel rna-guided nucleases and proteins for polymerase editing
WO2026003754A1 (en) 2024-06-25 2026-01-02 Life Edit Therapeutics, Inc. Novel reverse transcriptases and uses thereof

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5569597A (en) 1985-05-13 1996-10-29 Ciba Geigy Corp. Methods of inserting viral DNA into plant material
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4853331A (en) 1985-08-16 1989-08-01 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5039523A (en) 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
EP0388186A1 (en) 1989-03-17 1990-09-19 E.I. Du Pont De Nemours And Company External regulation of gene expression
ATE225853T1 (de) 1990-04-12 2002-10-15 Syngenta Participations Ag Gewebe-spezifische promotoren
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5498830A (en) 1990-06-18 1996-03-12 Monsanto Company Decreased oil content in plant seeds
CA2051562C (en) 1990-10-12 2003-12-02 Jewel M. Payne Bacillus thuringiensis isolates active against dipteran pests
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399680A (en) 1991-05-22 1995-03-21 The Salk Institute For Biological Studies Rice chitinase promoter
US5604121A (en) 1991-08-27 1997-02-18 Agricultural Genetics Company Limited Proteins with insecticidal properties against homopteran insects and their use in plant protection
TW261517B (enExample) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5789156A (en) 1993-06-14 1998-08-04 Basf Ag Tetracycline-regulated transcriptional inhibitors
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5608144A (en) 1994-08-12 1997-03-04 Dna Plant Technology Corp. Plant group 2 promoters and uses thereof
US5659026A (en) 1995-03-24 1997-08-19 Pioneer Hi-Bred International ALS3 promoter
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
AR014072A1 (es) 1998-02-26 2001-01-31 Pioneer Hi Bred Int Molecula de acido nucleico aislada que tiene una secuencia nucleotidica para un promotor que es capaz de iniciar una transcripcion constitutiva en unacelula de planta, construccion adn, vector, celula huesped, metodo para expresar en forma constitutiva una secuencia nucleotidica heteroloca en una
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6555655B1 (en) 1999-05-04 2003-04-29 Monsanto Technology, Llc Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants
US6593293B1 (en) 1999-09-15 2003-07-15 Monsanto Technology, Llc Lepidopteran-active Bacillus thuringiensis δ-endotoxin compositions and methods of use
US20050183161A1 (en) 2003-10-14 2005-08-18 Athenix Corporation AXMI-010, a delta-endotoxin gene and methods for its use
WO2005066202A2 (en) 2003-12-22 2005-07-21 E.I. Du Pont De Nemours And Company Bacillus cry9 family members
AU2007260716B2 (en) 2006-06-14 2013-05-02 BASF Agricultural Solutions Seed US LLC Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use
US8383604B2 (en) 2008-09-15 2013-02-26 Children's Medical Center Corporation Modulation of BCL11A for treatment of hemoglobinopathies
ES2609332T3 (es) 2009-07-02 2017-04-19 Athenix Corporation Gen pesticida AXMI-205 y métodos para su uso
WO2011084324A2 (en) 2009-12-21 2011-07-14 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis gene with lepidopteran activity
KR20160008655A (ko) 2009-12-24 2016-01-22 제이엑스 닛코 닛세키 킨조쿠 가부시키가이샤 가돌리늄제 스퍼터링 타깃 및 동 타깃의 제조 방법
WO2012024200A2 (en) 2010-08-19 2012-02-23 Pioneer Hi-Bred International, Inc. Novel bacillus thuringiensis gene with lepidopteran activity
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
AU2013266968B2 (en) * 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
EP3196301B1 (en) 2012-07-11 2018-10-17 Sangamo Therapeutics, Inc. Methods and compositions for the treatment of monogenic diseases
CA2930877A1 (en) * 2013-11-18 2015-05-21 Crispr Therapeutics Ag Crispr-cas system materials and methods
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
EP3186375A4 (en) 2014-08-28 2019-03-13 North Carolina State University Novel CAS9 PROTEINS AND CHARACTERISTICS FOR DNA TARGETING AND GENOME EDITING
EP3245232B1 (en) * 2015-01-12 2021-04-21 The Regents of The University of California Heterodimeric cas9 and methods of use thereof
AU2016263026A1 (en) * 2015-05-15 2017-11-09 Pioneer Hi-Bred International, Inc. Guide RNA/Cas endonuclease systems
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
EP3426780A1 (en) * 2016-03-11 2019-01-16 Pioneer Hi-Bred International, Inc. Novel cas9 systems and methods of use
EP3426778A1 (en) * 2016-03-11 2019-01-16 Pioneer Hi-Bred International, Inc. Novel cas9 systems and methods of use
CN109843914B (zh) * 2016-07-06 2024-03-15 沃泰克斯药物股份有限公司 用于治疗疼痛相关病症的材料和方法
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
EP3538661A4 (en) * 2016-11-14 2020-04-15 Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences METHOD FOR BASIC PROCESSING IN PLANTS
US11542496B2 (en) * 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
KR20240116572A (ko) * 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
SG11201906297QA (en) * 2017-03-24 2019-10-30 Curevac Ag Nucleic acids encoding crispr-associated proteins and uses thereof
US11345924B2 (en) * 2017-05-11 2022-05-31 Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences Creation of herbicide resistant gene and use thereof
EP3630849A4 (en) * 2017-05-25 2021-01-13 The General Hospital Corporation BIPARTITE BASIC EDITOR (BBE) AND TYPE II-C-CAS9 ZINC FINGER EDITOR ARCHITECTURES
WO2019036185A1 (en) * 2017-08-15 2019-02-21 The Regents Of The University Of California COMPOSITIONS AND METHODS FOR IMPROVING GENOMIC SEQUENCE CORRECTION
US11649442B2 (en) * 2017-09-08 2023-05-16 The Regents Of The University Of California RNA-guided endonuclease fusion polypeptides and methods of use thereof
CA3082450A1 (en) * 2017-11-21 2019-05-31 Crispr Therapeutics Ag Materials and methods for treatment of autosomal dominant retinitis pigmentosa
CA3084185A1 (en) * 2017-12-06 2019-06-13 Generation Bio Co. Gene editing using a modified closed-ended dna (cedna)
PL3802807T3 (pl) 2018-06-05 2025-03-31 Life Edit Therapeutics, Inc. Nukleazy kierowane rna i ich aktywne fragmenty oraz warianty i sposoby ich zastosowania
CN109837328B (zh) * 2018-09-20 2021-07-27 中国科学院动物研究所 核酸检测方法

Similar Documents

Publication Publication Date Title
JP2022545385A5 (enExample)
JP2021526853A5 (enExample)
JP2022516130A5 (enExample)
JP2023516226A5 (enExample)
JP7566853B2 (ja) Crispr/cpf1システム及び方法
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2025504898A5 (enExample)
JP2023541400A5 (enExample)
US7329742B2 (en) Aptamers and methods for their in vitro selection and uses thereof
FI4118198T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä
RU2017130143A (ru) Гибридные днк/рнк-полинукдеотиды crispr и способы
JP2023505600A5 (enExample)
JP2021518139A5 (enExample)
KR20180015731A (ko) 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정
RS61262B1 (sr) Novi postupci za proizvodnju oligonukleotida
JP2012520085A5 (enExample)
AU2020278864B2 (en) Single base substitution protein, and composition comprising same
JP2016537008A5 (enExample)
WO2024119625A1 (zh) 双链rna的合成方法及rna连接酶在双链rna合成中的应用
US12275951B2 (en) Engineered guide RNA and uses thereof
JP2024511131A5 (enExample)
JP2024522764A5 (enExample)
WO2018011236A1 (en) Prokaryotic argonaute proteins and uses thereof
CN104419704A (zh) 一种内含子来源环形rna分子及其成环关键核酸序列的应用
EP1419274A1 (en) Modular assembly of nucleic acid-protein fusion multimers